AI chatbot could spot breast cancer genes from family history

NCT ID NCT07070128

Recruiting now Diagnosis Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This study is testing an artificial intelligence tool that collects family cancer history through WhatsApp to predict genetic risk of breast cancer. Researchers will enroll 800 women already identified as high-risk by their doctors and compare the AI's predictions with standard genetic test results. The goal is to see if the AI can reliably identify who needs genetic counseling, potentially making risk assessment more accessible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this AI tool could help identify women at high genetic risk for breast cancer more easily, potentially leading to earlier genetic counseling and testing.
What could go wrong: This is an observational study, not a treatment trial. The AI tool may not be accurate enough to replace standard genetic testing, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASMS

Contacts and locations

Locations

Research Site
WITHDRAWN

Golania, Goiás, 74605-020, Brazil
Research Site
RECRUITING

Porto Alegre, Rio Grande do Sul, 90035-001, Brazil
Research Site
NOT_YET_RECRUITING

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.